CD8A and neoplasm: As for an impact on immune signaling, SRSF10 has recently been reported to inhibit the IFNα/IFNγ signaling pathway and suppress CD8+T cell infiltration, while its knockdown enhanced the anti-PD-L1-mediated anti-tumor activity [38].